Cargando…

Risk of Endometrial Cancer and Frequencies of Invasive Endometrial Procedures in Young Breast Cancer Survivors Treated With Tamoxifen: A Nationwide Study

BACKGROUND: Although the guidelines recommend gynecological assessment and close monitoring for symptoms of endometrial cancer in postmenopausal breast cancer survivors taking tamoxifen (TAM), the risk of endometrial cancer in young breast cancer survivors has not yet been fully assessed. This study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Soojeong, Lee, Young Jae, Jeong, Jae Ho, Jung, Jinhong, Lee, Jong Won, Kim, Hee Jeong, Ko, Beom Seok, Son, Byung Ho, Ahn, Sei Hyun, Lee, Yura, Chung, Il Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209428/ https://www.ncbi.nlm.nih.gov/pubmed/34150613 http://dx.doi.org/10.3389/fonc.2021.636378

Ejemplares similares

Endometrial polyp surveillance in premenopausal breast cancer patients using tamoxifen
por: Jeon, Se Jeong, et al.
Publicado: (2017)

Effect of Tamoxifen on the Risk of Osteoporosis and Osteoporotic Fracture in Younger Breast Cancer Survivors: A Nationwide Study
por: Lee, Jihyoun, et al.
Publicado: (2020)

Lymphedema in Endometrial Cancer Survivor: A Nationwide Cohort Study
por: Lee, Su-Jeong, et al.
Publicado: (2021)

Survival Outcome of Combined GnRH Agonist and Tamoxifen Is Comparable to That of Sequential Adriamycin and Cyclophosphamide Chemotherapy Plus Tamoxifen in Premenopausal Patients with Lymph-Node–Negative, Hormone-Responsive, HER2-Negative, T1-T2 Breast Cancer
por: Sohn, Guiyun, et al.
Publicado: (2016)

Prediction of Late Breast Cancer-Specific Mortality in Recurrence-Free Breast Cancer Survivors Treated for Five Years with Tamoxifen
por: Baek, Soo Yeon, et al.
Publicado: (2019)

Risk Factors Associated with Endometrial Pathology in Premenopausal Breast Cancer Patients Treated with Tamoxifen
por: Lee, Maria, et al.
Publicado: (2020)

Domestic medical travel from non-Seoul regions to Seoul for initial breast cancer treatment: a nationwide cohort study
por: Jeong, Jae Ho, et al.
Publicado: (2023)

Waiting Time for Breast Cancer Treatment in Korea: A Nationwide Cohort Study
por: Lee, Young-jin, et al.
Publicado: (2023)

Effectiveness of a 6-Month 22.5-mg Leuprolide Acetate Depot Formulation With Tamoxifen for Postoperative Premenopausal Estrogen Suppression in Hormone Receptor-Positive Breast Cancer
por: Wu, Zhen-Yu, et al.
Publicado: (2021)

Change in Estradiol Levels among Premenopausal Patients with Breast Cancer Treated Using Leuprolide Acetate 11.25 Milligrams 3-Month Depot and Tamoxifen
por: Lee, Young-jin, et al.
Publicado: (2020)

Molecular mechanisms of tamoxifen-associated endometrial cancer (Review)
por: HU, RONG, et al.
Publicado: (2015)

Tamoxifen and Endometrial Cancer: A Janus-Headed Drug
por: Emons, Günter, et al.
Publicado: (2020)

Risk of Endometrial Polyps, Hyperplasia, Carcinoma, and Uterine Cancer After Tamoxifen Treatment in Premenopausal Women With Breast Cancer
por: Ryu, Ki-Jin, et al.
Publicado: (2022)

Effects of Tamoxifen on Endometrial Carcinogenesis in Mice
por: Niwa, Kenji, et al.
Publicado: (1998)

Endometrial Surveillance in Tamoxifen and Letrozole Treated Breast Cancer Patients
por: AlZaabi, Adhari, et al.
Publicado: (2021)

Clinicopathological and molecular pathological characteristics in tamoxifen‑related endometrial cancer
por: Saeki, Harumi, et al.
Publicado: (2023)

Effects of hormone therapy on recurrence in endometrial cancer survivors: a nationwide study using the Korean Health Insurance Review and Assessment Service database
por: Cho, Hyun-Woong, et al.
Publicado: (2019)

Risk factors of progression to endometrial cancer in women with endometrial hyperplasia: A retrospective cohort study
por: Jeong, Jin Young, et al.
Publicado: (2020)

Hypertriglyceridemia is Frequent in Endometrial Cancer Survivors
por: Hirasawa, Akira, et al.
Publicado: (2013)

Risk factors for lower extremity lymphedema after surgery in cervical and endometrial cancer
por: Lee, Joongyo, et al.
Publicado: (2022)

Long-term outcomes of magnetic resonance imaging-invisible endometrial cancer
por: Choi, Hyun-Jin, et al.
Publicado: (2016)

Surveillance for endometrial cancer with transvaginal ultrasonography of breast cancer patients under tamoxifen treatment
por: Ciatto, S, et al.
Publicado: (2003)

Event-free survival following early endometrial events in breast cancer patients treated with anti-hormonal therapy: A nationwide claims data study
por: Lee, Yura, et al.
Publicado: (2019)

Effect of standard low-dose anthracycline chemotherapy on late congestive heart failure in breast cancer survivors aged between 50 and 59 at diagnosis: A nationwide study
por: Chung, Il Yong, et al.
Publicado: (2020)

G-protein coupled receptor 64 (GPR64) acts as a tumor suppressor in endometrial cancer
por: Ahn, Jong Il, et al.
Publicado: (2019)

Endometrial cancer and antidepressants: A nationwide population-based study
por: Lin, Chiao-Fan, et al.
Publicado: (2016)

A Case of Pancreatic Endometrial Cyst
por: Lee, Dong Soo, et al.
Publicado: (2002)

The Role of ROR1 in Chemoresistance and EMT in Endometrial Cancer Cells
por: Lee, Kyung-Jun, et al.
Publicado: (2023)

Sleep quality of endometrial cancer survivors and the effect of treatments
por: Tuyan İlhan, Tolgay, et al.
Publicado: (2017)

Quality of life in endometrial cancer survivors by grade of disease
por: Banning, K., et al.
Publicado: (2023)

G-protein coupled receptor 64 is required for decidualization of endometrial stromal cells
por: Yoo, Jung-Yoon, et al.
Publicado: (2017)

Psychiatric comorbidities among endometrial cancer survivors in South Korea: a nationwide population-based, longitudinal study
por: Heo, Jaesung, et al.
Publicado: (2018)

Second primary colorectal cancer among endometrial cancer survivor: shared etiology and treatment sequelae
por: Lim, Myong Cheol, et al.
Publicado: (2018)

Collision of Three Histologically Distinct Endometrial Cancers of the Uterus
por: Jang, Ki-Seok, et al.
Publicado: (2012)

Circulating Levels of Agouti-Related Peptide in Endometrial Cancer Survivors
por: Bienertova-Vasku, Julie, et al.
Publicado: (2011)

Reassessment of intensive surveillance practices adopted for endometrial cancer survivors
por: Nakamura, Kazuto, et al.
Publicado: (2022)

Potential of MALDI-TOF-based serum N-glycan analysis for the diagnosis and surveillance of breast cancer
por: Lee, Jong Won, et al.
Publicado: (2020)

Prescription Refill Gap of Endocrine Treatment from Electronic Medical Records as a Prognostic Factor in Breast Cancer Patients
por: Lee, Yura, et al.
Publicado: (2019)

Endocrine Risk Factors of Endometrial Cancer: Polycystic Ovary Syndrome, Oral Contraceptives, Infertility, Tamoxifen
por: Ignatov, Atanas, et al.
Publicado: (2020)

A retrospective prognostic evaluation analysis using the 8th edition of the American Joint Committee on Cancer staging system for breast cancer
por: Lee, Sae Byul, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_mereidt2pu5dnuchl2icvkgk1m